Excitatory amino acids (EAAs) likely constitute the most important class of excitatory neurotransmitters in mammalian central nervous system. Their rapid action and ubiquitous presence underlie their pivotal role synaptic communication between neurons at all levels of the neuraxis. The spinal cord is no exception, and primary afferent sensory neurons contain and release glutamate or aspartate in the dorsal horn. The goal of this project is to examine the participation of endogenous EAAs and EAA receptors in the transmission of nociceptive information through the dorsal horn of rats and in synaptic remodeling which may accompany prolonged activation. This project will examine the spinal function of excitatory amino acids (EAAs) and, to a lesser extent substance P (SP), in the transmission of nociceptive signals, and will elucidate antinociceptive mechanisms and assign cellular sites of action to opioid, serotonergic and GABAergic agonists in the spinal cord. We will test several hypotheses concerning the juxtaposition of receptors for these neurotransmitters on common neurons and/or synaptic elements. In addition, we will examine their involvement in development of long term changes in spinal circuitry following chronic changes in afferent input. In conjunction with the first aim above, the experiments will test the participation of EAAs in the relay of information from primary afferent sensory fibers secondary neurons in the spinal cord dorsal horn and of the effects of GABA, opioids, serotonin and cocaine on that transmission. In conjunction with the second aim above, the experiments will evaluate the participation of EAAs in transsynaptic activation of the c-fos protooncogene and in induction of synaptic and neuronal alterations after prolonged activation. The experiments will be carried out at several levels from whole animal electrophysiology, to spinal cord slice intracellular recording, to dissociated neuron recording, to expression of neurotransmitter receptors in oocytes. The results will significantly improve our understanding of spinal nociceptive transmission and analgesic mechanisms, and of spinal mechanisms of adaptation to prolonged stimulation. Understanding analgesic mechanisms at this level of resolution is crucial to the design of new manipulations with enhanced analgesic efficacy and reduced abuse liability.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA004274-04
Application #
3209685
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1987-02-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Stone, Laura S; German, Jonathan P; Kitto, Kelly F et al. (2014) Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects. PLoS One 9:e109903
Stone, Laura S; Kitto, Kelley F; Eisenach, James C et al. (2007) ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors. J Pharmacol Exp Ther 323:899-906
Laughlin, T M; Bethea, J R; Yezierski, R P et al. (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84:159-67
Fairbanks, C A; Nguyen, H O; Grocholski, B M et al. (2000) Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology 93:765-73
Fairbanks, C A; Posthumus, I J; Kitto, K F et al. (2000) Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice. Pain 84:13-20
Fairbanks, C A; Wilcox, G L (2000) Spinal plasticity of acute opioid tolerance. J Biomed Sci 7:200-12
Fairbanks, C A; Wilcox, G L (1999) Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290:403-12
Fairbanks, C A; Wilcox, G L (1999) Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Exp Ther 288:1107-16
Laughlin, T M; Kitto, K F; Wilcox, G L (1999) Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia. Pain 80:37-43
Fairbanks, C A; Wilcox, G L (1997) Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 282:1408-17

Showing the most recent 10 out of 33 publications